These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

964 related items for PubMed ID: 9300034

  • 1. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L, Schirmbeck R, Reimann J, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):26-39. PubMed ID: 9300034
    [Abstract] [Full Text] [Related]

  • 2. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L, Kratochwil G, Osterrieder N, Knüchel R, Wolf H, Wagner R.
    Virology; 1997 Aug 18; 235(1):10-25. PubMed ID: 9300033
    [Abstract] [Full Text] [Related]

  • 3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 18; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 4. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles.
    Wagner R, Deml L, Schirmbeck R, Niedrig M, Reimann J, Wolf H.
    Virology; 1996 Jun 01; 220(1):128-40. PubMed ID: 8659105
    [Abstract] [Full Text] [Related]

  • 5. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.
    Luo L, Li Y, Chang JS, Cho SY, Kim TY, Choi MJ, Cheong HS, Kim HJ, Ahn HJ, Min MK, Chun BH, Jung SM, Woo SG, Park SY, Kang CY.
    Virology; 1998 Jan 20; 240(2):316-25. PubMed ID: 9454705
    [Abstract] [Full Text] [Related]

  • 6. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R, Deml L, Fliessbach H, Wanner G, Wolf H.
    Virology; 1994 Apr 20; 200(1):162-75. PubMed ID: 7510434
    [Abstract] [Full Text] [Related]

  • 7. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ, Li GH, Fong SE, Nagashima K, Gonda MA.
    Virology; 1997 Sep 29; 236(2):307-15. PubMed ID: 9325238
    [Abstract] [Full Text] [Related]

  • 8. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R, Deml L, Schirmbeck R, Reimann J, Wolf H.
    Behring Inst Mitt; 1994 Dec 29; (95):23-34. PubMed ID: 7755506
    [Abstract] [Full Text] [Related]

  • 9. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F, Stahl-Hennig C, Dittmer U, Wolf H, Wagner R.
    Biol Chem; 1999 Mar 29; 380(3):341-52. PubMed ID: 10223337
    [Abstract] [Full Text] [Related]

  • 10. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 11. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.
    Doe B, Steimer KS, Walker CM.
    Eur J Immunol; 1994 Oct 15; 24(10):2369-76. PubMed ID: 7523139
    [Abstract] [Full Text] [Related]

  • 12. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
    Wild J, Bojak A, Deml L, Wagner R.
    Vaccine; 2004 Apr 16; 22(13-14):1732-43. PubMed ID: 15068857
    [Abstract] [Full Text] [Related]

  • 13. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R, Böltz T, Deml L, Modrow S, Wolf H.
    J Gen Virol; 1993 Jul 16; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [Abstract] [Full Text] [Related]

  • 14. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team.
    J Infect Dis; 2001 Feb 15; 183(4):563-70. PubMed ID: 11170981
    [Abstract] [Full Text] [Related]

  • 15. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT, Boo I, Drummer HE, Netter HJ.
    Antivir Ther; 2007 Feb 15; 12(4):477-87. PubMed ID: 17668556
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
    Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA.
    J Immunol; 1994 Jun 15; 152(12):5603-12. PubMed ID: 7515908
    [Abstract] [Full Text] [Related]

  • 17. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
    Akerblom L, Nara P, Dunlop N, Putney S, Morein B.
    Biotechnol Ther; 1993 Jun 15; 4(3-4):145-61. PubMed ID: 8292967
    [Abstract] [Full Text] [Related]

  • 18. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP, Young KR, Ross TM.
    Virology; 2007 Feb 20; 358(2):334-46. PubMed ID: 17011011
    [Abstract] [Full Text] [Related]

  • 19. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein.
    Bergmann C, Stohlmann SA, McMillan M.
    Eur J Immunol; 1993 Nov 20; 23(11):2777-81. PubMed ID: 7693478
    [Abstract] [Full Text] [Related]

  • 20. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
    Stanhope PE, Liu AY, Pavlat W, Pitha PM, Clements ML, Siliciano RF.
    J Immunol; 1993 May 15; 150(10):4672-86. PubMed ID: 8097759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.